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SUMMARY.-On the basis of histological sections and cytological smears in
110 cases, the " reticulosarcomas " (exclusive of Ewing's sarcoma and reticulo-
sarcomas of bone marrow) were divided into two varieties: histiocytic types and
histioblastic types.
The correlation between the histological and cytological evaluation was
excellent in each case; only those tumours classified as histiocytic presented a
continuous and abundant network of reticulin.
The histioblastic type predominated in the male sex. The difference in the
clinical expressions of the two varieties is not statistically significant, except as
to the frequency of cutaneous lesions: 27.7% in the histiocytic type and 2 6% in
the histioblastic type.
While the duration of their evolution is not different, only the histioblastic
type is transformed into leukaemia, which is of the " monoblastic " type: this
transformation was observed in 17.5% of cases, while it was never observed in
histiocytic type.
THE term " reticulosarcoma " was given by Oberling (1928) to a neoplastic
disease formerly described by Ghon and Roman (1916) under the name " reticulum
cell lymphosarcoma ", by Silhol and Rouslacroix (1924) under the term " peri-
thelial cell sarcoma ", by Goormaghtig (1925) under the denomination " malignant
proliferation of lymph node reticulo-endothelial tissue ", and by Roulet (1930)
under the term " retothelsarkom ".
The nosological entity of Oberling has raised discussions on three points: (a)
whereas this author included Ewing's " myeloma " (1921, 1924, 1939, 1940), most
of the authors class it separately, designating it " Ewing's sarcoma " (Foote and
Anderson, 1941; McCormak et al., 1952; Lichtenstein, 1952; Friedman and Gold,
1968); (b) whereas certain authors separate reticulosarcoma ofthe bone (Oberling,
1928; Parker and Jackson, 1939; McCormak et al., 1952) and lymphoid reticulo-
sarcoma (Sabrazes and Duperie, 1929; Roulet, 1930, 1932; Cracium and Ursu,
1933; Adam, 1934; Stevenin et al., 1935), others (Mathe and Seman, 1963) do not
see any histocytological difference according to the localisation of the " reticulo-
sarcoma ", while recognising that the prognosis and the progression of the disease
can be different according to its initial localisation (Dustin and Howet, 1949); (c)
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whereas most histopathologists do not try to distinguish several histocytological
varieties of reticulosarcoma (some barely separate the reticulosarcomas from
lymphosarcomas (Van Der Werf-Messing, 1968)), others distinguish two histologic
types as follows: (1) " undifferentiated " reticulosarcomas (Oberling, 1928; Robb-
Smith, 1938;Rappaport, 1964) or retothelsarkom, " unreife "form (Roulet, 1930),
that Warren and Picena (1941) still describe as "syncytial "reticulosarcoma, and
Mathe and Seman (1963) as " histioblastic" reticulosarcoma and (2) " dif-
ferentiated " reticulosarcoma (Oberling, 1928) or retothelsarkom, "reife " form
(Roulet, 1930) or " clasmatocytic" (Gall and Mallory, 1942), or "dictyocytic "
(fibrillary) (Robb-Smith, 1938) or "histiocytic " (Bessis, 1946; Mathe and Seman,
1963; Rappaport, 1964).
Certain authors consider the first as a neoplastic proliferation of " primitive"
reticular cells (see Rappaport, 1964), which are considered by them as the pluri-
potential cells of Maximov and Bloom (1942), the second as a proliferation of
histiocytes which are derived from the " primitive reticular cell ", either directly
or through an undifferentiated haemopoietic stem cell (Rappaport, 1964).
The present studies on the cytogenesis of blood cells have not enabled us to
define more accurately the relations between these different cells; it is only known
that the stem cell precursors of macrophages are situated in the bone marrow, as
only the graft of bone marrow, the stem cells of which are labelled with tritiated
thymidine, replenishes the organism with labelled histiocytes (Balner, 1963;
Goodman, 1964; Virolainen, 1968). This experimental data is hardly in favour of
the hypothesis that histiocytes originate from reticular cells which are dis-
seminated in the organism, but is more in favour of the hypothesis according to
which histiocytes originate from a medullary stem cell as is the case with lympho-
cytes. Also, as the stem cell of lymphocytes is called a lymphoblast, we call the
stem cell ofhistiocytes a " histioblast " in accordance with Bessis (1946). At the
same time, as there exist two types of lymphosarcoma, lymphocytic lympho-
sarcoma(differentiated) andlymphoblasticlymphosarcoma (slightlydifferentiated),
there exist two types of" reticulosarcomas ", the histiocytic or differentiated form,
and the poorly differentiated form composed ofcells resembling blasts, and it is for
this reason that we have designated it " histioblastic ".
In the present work, we have compared (1) the histological aspects ofsections,
(2) the cytological aspects of smears and/or imprints, and (3) the clinical and
evolutive aspects of the two varieties of " reticulosarcomas ", namely histiocytic
and histioblastic. We have also comparedthehistocytologicalfeatures asrevealed
under the light microscope with the electron microscopic aspects ofthese tumours.
METHODS AND PATIENTS
From 1960 to 1968, 110 cases with the diagnosis of " reticulosarcoma " were
included in a study consisting of: (a) analysis of clinical data and progress; (b)
reading ofhistological sections and smears ofpunctures and/or imprints oftumour
tissue, and histocytological comparison done according to the double blind
method. A certain number of tumours were also the subject of electron micro-
scopic studies.
The histological study included reticulin stains by the method of Foote (Foote
and Anderson, 1941). Smears were stained by May-Grunwald-Giemsa stain.
Cases of Ewing's sarcoma, " reticulosarcomas " starting in the bone marrow.
688TWO VARIETIES OF "RETICULOSARCOMAS 68
" reticulo-lymphosarcoma ", and cases ofgiant follicular lymphoma were excluded
from the study.
On reading the histological sections, the name histiocytic sarcomas (HC S) (Fig. 1)
was given to those tumours composed offree cells, having variable morphology and
form, in which the nuclei were often distorted, monocytoid, with coarse chromatin,
often containing one or several nucleoli; the cytoplasm often contained vacuoles,
and was slightly basophilic; the nuclear-cytoplasmic ratio was that of blood
monocytes which the tissue histiocytes closely resembled. The name histioblastic
sarcoma (HB S) (Fig. 2) was given to tumours which were composed of free cells,
having similar morphology andform but which were moreregular, and inwhichthe
nuclei were ofregular contours, round, square or rectangular, with regular and fine
chromatin and contained one or several nucleoli with slightly basophilic cytoplasm.
These features were similar to those of lympho(blasto)sarcoma, but the cells of
histioblastosarcoma were generally bigger.
On reading the cytological smears, the tumour was named histiocytic sarcoma
(Fig. 3) when more or less dystrophic free cells were found which resembled normal
histiocytes; these elements were of variable size and had slightly basophilic cyto-
plasm often containing granules andsometimesphagocytosed material. Thenuclei
were of variable form, often irregular, with coarse chromatin and rarely with
demonstrable nucleoli. The tumour was termed histioblastic sarcoma (Fig. 5)
when more or less dystrophic, completely free, cells which resembled normal
histioblasts were found in the smear (see Bessis, 1946; Mathe and Seman, 1963):
these cells had the typical appearance of blasts: notably basophilic cytoplasm,
increased nuclear-cytoplasmic ratio, nuclei with regularly reticulated chromatin,
sometimes "combed " when the cell was spread in a single diameter, containing
one or several nucleoli; these cells were generally bigger than lymphoblasts, and
differed from them by their less increased nuclear-cytoplasmic ratio and their
greater number of nucleoli.
The electron microscopic study was in perfect agreement with the data of the
studies of histological sections, cytological smears and imprints. In the case of
histiocytosarcoma (Fig. 5 and 6), the tumour was composed ofcells ofmore unequal
size, with a smaller nuclear-cytoplasmic ratio than in histioblastosarcoma, having
nuclei with chromatin in clumps. Above all, one could see reticulin fibrils emerg-
ing from certain cells; in contrast, in the case ofhistioblastosarcoma (Fig. 7 and 8),
the tumour was composed ofcells oflessvariablesize, withamoreincreasednuclear-
cytoplasmic ratio, with regular chromatin, and with frequent nucleoli; no reticulin
was evident.
These patients were treated by methodswhich didnot differinthe two varieties,
and the principles of which were as follows (see Mathe, 1966): (1) stages I and II:
first extended and intensive radiotherapy, followed by complementary chemo-
therapy for 3 years (vinblastin); (2) stages III and IV: first intensive chemo-
therapy (association ofprednisone, methylhydrazine and TEM), followed by com-
plementary radiotherapy on the remaining lesions or on all the lesions present
initially; (3) leukaemic stage: chemotherapy.
RESULTS
(1) Correlation between the histological and cytological expressions
Table I shows the good correlation between the diagnoses made on the sections
and on the smears. It shows particularly that only histiocytic sarcomasfrequently
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present an intense network of reticulin (Fig. 9 and 10). This confirms the electron
microscopic observations.
TABLE I.-Relationship Between the Histological Diagnosis and the Cytological
Diagnosis. State of the Reticulin Network
Histological Relationship of Marked and extended
diagnosis cytological diagnosis reticulin network
Histiocytosarcoma
36 cases . 30 cases (84%) 22 cases (60%)
Histioblastosarcoma
74 cases . 59 cases (80%) . 4 cases (5%)
It goes without saying, however, that a definitive diagnosis cannot be made
from the cytological examination ofsmears alone: gross errors could be committed,
such as confusionwith othersarcomas orepithelialneoplasms; whateverthe variety
of " reticulosarcoma ", the diagnosis can be established either by the examination
of histological sections, or, even better, by comparing the histological and cyto-
logical features ofthe tumour.
(2) Correlations between the histological, cytological and clinical observations
It can be seen in Table II, which gives the distribution ofthe 110 cases studied,
that histioblastosarcoma is noticeably more frequent than histiocytosarcoma.
TABLE II.-Frequency and Distribution of the Two Varieties According to Sex
Number Male Female Statistical
Histo-cytologic type of cases subjects subjects significance
Histiocytosarcoma . 36 23 (64%) . 13 (36%)
Histioblastosarcoma . 74 . 52 (70%) . 22 (30%) . Significant to 5%
Table II gives the distribution according to age at the beginning ofthe disease.
No significant difference is noted between the two varieties.
Table II shows again the significantly higher frequency of histioblastosarcoma
in subjects of the male sex.
Table III indicates the nature of the first manifestations in the two varieties:
while differences seem to be evident, none is significant.
EXPLANATION OF PLATES
FIG. 1.-Histological aspect of a histiocytosarcoma. Haematin-eosin. x 370.
FIG. 2.-Histological aspect of a histioblastosarcoma. Haematin-eosin. x 370.
FIG. 3. Cytological aspect of a histiocytosarcoma. May-Grunwald-Giemsa. x 1500.
FIG. 4.-Cytological aspect of a histioblastosarcoma. May-Grunwald-Giemsa. x 1500.
FIG. 5 and 6.-Electron microscopic aspect of a histiocytosarcoma. Note reticulin (indicated
by arrows). Uranyl acetate 30', lead citrate'. x 4500.
FIG. 7 and 8.-Electron microscopic aspect of a histioblastosarcoma. Uranyl acetate 30',
lead citrate 5'. x 4500.
FIG. 9.-Reticulin staining by the silver impregnation method. The reaction is positive in the
case of histiocytosarcoma.
FIG. 10. Reticulin staining by the silver impregnation method. The reaction is negative in
the case of histioblastosarcoma.
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FIG. 11. Distribution of patients in the two varieties of reticulosareomas according to age at
the beginning of the illness.
Table IV indicates the different manifestations occurring during the total
evolution. Only the highfrequency of cutaneous manifestations in histiocytosarcoma
is significant, while they are exceptional in the other variety.
TABLE V.-Evolutive Modalities of the Two Varieties
Localised forms in the Transformation into
Histo-cytologic type beginning acute leukaemia Survival to 5 years
Histiocytosarcoma . 6 (16 6%o) . 0 1255%
Histioblastosarcoma . 12 (16%) . 13 (17 50°) 10%
Table V compares the clinical evolution of the two neoplasms: while the
respective frequencies of localised forms (stages I and II) and of disseminated and
generalised forms (stages III and IV) do not differ when the disease becomes
clinically apparent and, while the duration ofsurvival is the same, one is struck by
one significant difference: only histioblastosarcoma isfrequently complicated (17.50/
of cases) by a transformation into leukaemia.
(3) Leukaemia secondary to histioblastic reticulosarcoma
This acute leukaemia secondary to histioblastic reticulosarcoma merits some
comments: as shown in Table VI, the leukaemia appears after a non-leukaemic
period varying from 1 month to 1 year. It can be discovered earlier by systematic
studyofbuffy-coatsthanbybonemarrowexaminations; thefirstshowsan abnormal
level of " monoblasts ", the second shows progressive invasion of the marrow by
similar cells: the esterase reaction, when done, is positive, while the PAS, Sudan
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blue and peroxidase reactions are negative. In one case the monoblasts were
associated with myeloblasts.
The term of " monoblastic " leukaemia merits a comment: it signifies that the
tumour cells that characterise this leukaemia do not differ from those of the
primitive monoblastic leukaemia (see Mathe and Seman, 1963). Isthis to say that
the "monoblast " and " histioblast " are one and the same cell, as " monocyte "
and "histiocyte " correspond to the two " circulating " and " tissue " aspects of
the same cell, that couldbe called a " histiomonocyte "? We areinclinedto accept
this, but at the same time we consider it reasonable to retain the concept of the
duality ofthese cells until valid cytochemical and, above all, physiological studies
provide us with more information on this problem.
This syndrome of " transformation " of sarcoma into leukaemia can appear
when the sarcoma is clinically evident or in the course of a remission. The
sensitivity to therapeutic agents is not exceptional (5 cases out of 10). We have
obtained apparently complete remissions by the combined use of prednisone and
vincristin, of prednisone, methylhydrazine and TEM, of cytosine arabinoside
alone, of prednisone alone, and an incomplete remission with methotrexate
administered athigh doses. Table VI showsthatthe survival afterthe appearance
ofthe leukaemia syndrome varies from 15 days to one month when a remission is
not obtained, and from 2 to 6 months when a " complete remission " is obtained.
The authors wish to thank Doctors G. de The and J. P. Thierry for their kind
adviceontheinterpretation ofelectronmicroscopyimagesandDrHenryRappaport
for his comments.
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